Financial Performance - Revenue for the six months ended June 30, 2025, was RMB 3,655,550, a decrease from RMB 6,355,418 in the same period of 2024, representing a decline of approximately 42.3%[18]. - The company reported a pre-tax loss of RMB 315,610 for the first half of 2025, compared to a pre-tax loss of RMB 242,212 in the first half of 2024[18]. - The gross profit for the six months ended June 30, 2025, was RMB 0.9 million, a turnaround from a gross loss of RMB 23.8 million in the same period of 2024, attributed to optimized production processes and higher gross margins from overseas sales[39]. - The company reported a net loss of RMB 263,655 for the six months ended June 30, 2025, compared to a net loss of RMB 166,337 in 2024, reflecting a worsening financial position[97]. - The total comprehensive loss for the six months ended June 30, 2025, was RMB 263,707,000, compared to a loss of RMB 166,337,000 for the same period in 2024[102]. Market and Industry Focus - The company is focused on expanding its market presence and enhancing its product offerings in the new energy sector[3]. - The company is focused on the photovoltaic industry chain, particularly in the research, development, production, and sales of photovoltaic cells[19]. - The company aims to enhance its core technology and product quality to lead the global photovoltaic industry in technological upgrades[23]. - The company is committed to the "dual carbon" strategy and aims to contribute to the green development mission in the renewable energy sector[23]. - The photovoltaic industry is entering a de-capacity phase, with many small and less competitive companies exiting the market, leading to improved supply-demand relationships[26]. Strategic Initiatives - The company aims to leverage its strategic committees to drive growth and innovation in the renewable energy market[9]. - The company is constructing an overseas photovoltaic cell production base with an annual capacity of approximately 5 GW[16]. - The company aims to fill the overseas battery production gap through joint ventures and collaborations with global component customers[30]. - The company is preparing for the mass production of TBC batteries, which have a conversion efficiency improvement of 1-1.5 percentage points over mainstream N-type batteries[33]. - The company plans to continue its focus on research and development in photovoltaic technology to enhance product offerings and market competitiveness[107]. Shareholder and Governance Information - The company is committed to compliance with corporate governance codes as per Hong Kong listing rules[12]. - The board of directors includes executive directors and independent non-executive directors, with recent changes in appointments noted[8]. - The company has a significant shareholder group, with the Yang family holding 80% of Hainan Jindi Technology Investment Co., Ltd.[13]. - The company has implemented employee incentive plans with varying vesting periods, including a 2021 plan with a 48-month exercise period[78]. - The company has established a remuneration and assessment committee to review the compensation policies for directors and senior management[90]. Financial Position and Assets - Total assets increased to RMB 18,414,446 as of June 30, 2025, up from RMB 16,444,209 as of December 31, 2024, reflecting a growth of approximately 11.9%[18]. - The total equity rose to RMB 4,812,261 as of June 30, 2025, compared to RMB 3,886,997 as of December 31, 2024, indicating an increase of about 23.8%[18]. - Cash and cash equivalents increased by approximately 24.3% from RMB 2,616.3 million as of December 31, 2024, to RMB 3,253.1 million as of June 30, 2025, mainly due to proceeds from a global offering[49]. - The debt-to-asset ratio improved from approximately 76.4% as of December 31, 2024, to about 73.9% as of June 30, 2025, indicating a stronger capital structure[51]. - The company has a total of 229,151,752 A-shares and 63,432,300 H-shares issued as of June 30, 2025[80]. Cash Flow and Investments - For the six months ended June 30, 2025, the company reported a net cash inflow from operating activities of RMB 1,031,897,000, a significant increase from RMB 130,421,000 in the same period of 2024[104]. - The company reported a net cash outflow from investing activities of RMB 3,036,649,000 for the six months ended June 30, 2025, compared to RMB 275,395,000 in the same period of 2024[104]. - The company raised RMB 1,304,294,000 from the issuance of ordinary shares during the financing activities for the six months ended June 30, 2025[104]. - The company has not made any significant investments or acquisitions during the reporting period, but continues to seek new business development opportunities[66]. - The company issued 63,432,300 shares at HKD 22.15 per share during its IPO, raising a total of RMB 1,305,310,000[146]. Employee and Compensation - Employee costs decreased by approximately 40.1% from RMB 445.38 million for the six months ended June 30, 2024, to RMB 266.59 million for the same period in 2025, mainly due to workforce reduction[59]. - The total compensation for key management personnel for the six months ended June 30, 2025, was RMB 4,406,000, compared to RMB 4,256,000 for the same period in 2024[158]. - The company emphasizes employee compensation policies, including salaries and benefits, to attract qualified employees[90]. - The employee incentive plan awarded a total of 14,030,500 A shares, with 2,602,347 A shares remaining unexercised as of June 30, 2025[75]. - The company’s stock option plans aim to align the interests of eligible participants with those of shareholders, enhancing overall company success[147]. Regulatory and Compliance - The company is committed to maintaining high standards of corporate governance and has adhered to the corporate governance code throughout the reporting period[91]. - The company has not established any equity-related agreements or arrangements for the period ending June 30, 2025, indicating a conservative approach to capital management[94]. - The company did not declare any interim dividends for the six months ending June 30, 2025[72]. - No significant events occurred after June 30, 2025, that would materially impact the group's operational and financial performance[70]. - The company has not disclosed any additional interests or holdings by directors, supervisors, or senior executives beyond what has been reported[83].

Group 1 - The article highlights the top three companies with the highest AH premium rates as Northeast Electric (00042) at 743.75%, Hongye Futures (03678) at 241.98%, and Andeli Juice (02218) at 236.37% [1] - The bottom three companies with the lowest AH premium rates include Ningde Times (03750) at -16.43%, Heng Rui Medicine (01276) at 1.82%, and Midea Group (00300) at 4.90% [1] - The article provides a detailed table of the top ten and bottom ten AH stocks based on premium rates and deviation values, indicating significant disparities in market valuations between H-shares and A-shares [1][2] Group 2 - The deviation values for the top three companies are Andeli Juice (02218) at 32.29%, Jinli Permanent Magnet (06680) at 22.19%, and Beijing Machinery (00187) at 20.80% [1] - The companies with the lowest deviation values include BYD Company (01211) at -98.36%, Northeast Electric (00042) at -64.84%, and Longpan Technology (02465) at -51.92% [1][2] - The article emphasizes that the deviation value represents the difference between the current premium rate and the average premium rate over the past 30 days, providing insights into market trends [2]

Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2025, representing a 20% increase compared to the same period last year[3]. - For the six months ended June 30, 2025, the company reported revenue of RMB 3,655,550, a decrease from RMB 6,355,418 in the same period of 2024[17]. - The company experienced a pre-tax loss of RMB 315,610 for the first half of 2025, compared to a pre-tax loss of RMB 242,212 in the first half of 2024[17]. - The gross profit for the six months ended June 30, 2025, was RMB 0.9 million, a turnaround from a gross loss of RMB 23.8 million in the same period of 2024[38]. - The company recorded a loss of RMB 263.7 million for the six months ended June 30, 2025, compared to a loss of RMB 166.3 million in the same period of 2024[42]. - The company reported a basic and diluted loss per share of RMB 1.07, compared to RMB 0.94 in the previous year[96]. - The net loss for the period was RMB 263,655, compared to a net loss of RMB 166,337 in the previous year, representing an increase in losses of 58.5%[96]. Revenue Breakdown - Revenue for the six months ended June 30, 2025, was RMB 3,655,550,000, a decrease of approximately 42.5% compared to RMB 6,355,418,000 in the same period of 2024, primarily due to a 67.9% decline in the mainland China market[35]. - Revenue from mainland China was RMB 1,755,392,000, down from RMB 5,476,337,000 in 2024, while revenue from overseas customers increased to RMB 1,900,158,000 from RMB 879,081,000[116]. - Major customer A contributed RMB 467,940,000, representing over 10% of total revenue, compared to RMB 1,203,320,000 in 2024[117]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 30% market share by the end of 2026[3]. - The company aims to leverage its technological advantages in battery production to expand its presence in overseas markets and enhance its supply capabilities[24]. - The company is exploring diverse models for overseas capacity construction, including technical cooperation and investment partnerships, to meet growing global photovoltaic market demands[30]. - The company plans to continue its focus on research and development in photovoltaic technology to enhance product offerings and market competitiveness[106]. Research and Development - Research and development expenses increased by 10% to RMB 50 million, focusing on innovative energy solutions[3]. - The company is focusing on the research and development of photovoltaic cells, which are critical for improving energy conversion efficiency and reducing costs[20]. - The company is actively developing TBC batteries, with laboratory efficiency reaching 32.08% for perovskite tandem cells, indicating its commitment to leading technology advancements[32]. - Research and development expenses decreased to RMB 74,458 from RMB 111,448, reflecting a reduction of 33.2% year-over-year[96]. Financial Position - Total assets increased to RMB 18,414,446 as of June 30, 2025, up from RMB 16,444,209 as of December 31, 2024[17]. - The company's total equity rose to RMB 4,812,261 as of June 30, 2025, compared to RMB 3,886,997 at the end of 2024[17]. - Cash and cash equivalents increased to RMB 3,253.1 million as of June 30, 2025, primarily due to proceeds from the global offering[48]. - The debt-to-asset ratio decreased from approximately 76.4% as of December 31, 2024, to approximately 73.9% as of June 30, 2025, and the current ratio improved from 1.0 times to 1.2 times[50]. Stock and Shareholder Information - The company has granted stock options under various employee incentive plans, with the latest plan (2023 B-type) allowing for 50% vesting after 12 months and the remaining 50% after 36 months[77]. - The total number of stock options granted but not exercised is 8,576,331, with 5,973,984 options exercised during the reporting period[76]. - The company’s board members and executives hold a total of 51,803,865 A-shares, representing 22.61% of the total shareholding[79]. - The company has adopted an employee incentive plan to reward eligible employees with share options[89]. Corporate Governance - The company is committed to maintaining high standards of corporate governance and has complied with the corporate governance code throughout the reporting period[90]. - The company has not reported any changes in board member information during the reporting period[78]. - The company maintains compliance with Hong Kong Stock Exchange regulations regarding the disclosure of director and executive interests[79]. Future Outlook - The company aims to reduce carbon emissions by 50% by 2030 as part of its sustainability strategy[3]. - The company’s future outlook includes continued expansion in employee incentive plans to align interests with shareholders[77]. - The company plans to continue expanding its market presence and investing in new technologies as part of its growth strategy[146].

Core Insights - The article highlights the top and bottom AH share premium rates as of August 21, with Northeast Electric (00042), Andeli Juice (02218), and Hongye Futures (03678) leading in premium rates, while CATL (03750), Heng Rui Medicine (01276), and Midea Group (00300) lag behind [1][2] Premium Rate Summary - The top three AH share premium rates are as follows: - Northeast Electric (00042): 757.14% - Andeli Juice (02218): 237.73% - Hongye Futures (03678): 236.54% [2] - The bottom three AH share premium rates are: - CATL (03750): -17.69% - Heng Rui Medicine (01276): -2.65% - Midea Group (00300): 5.19% [2] Deviation Value Summary - The top three stocks with the highest deviation values are: - Andeli Juice (02218): 38.61% - Beijing Machinery (00187): 30.46% - Junda Co. (02865): 17.54% [1][3] - The bottom three stocks with the lowest deviation values are: - BYD (01211): -111.35% - Northeast Electric (00042): -64.92% - Longpan Technology (02465): -46.48% [1][3]

截止8月15日收盘，东北电气(00042)、弘业期货(03678)、安德利果汁(02218)分列AH溢价率前三位，溢 价率分别为770.97%、226.69%、213.19%；宁德时代(03750)、恒瑞医药(01276)、紫金矿业(02899)分列 AH溢价率末三位，溢价率分别为-19.95%、-7.45%、5.81%。其中安德利果汁(02218)、金力永磁 (06680)、南京熊猫电子股份(00553)的偏离值位居前三，分别为21.03%、11.03%、10.63%；另外，比亚 迪股份(01211)、东北电气(00042)、龙蟠科技(02465)的偏离值位居后三，分别 为-143.50%、-80.62%、-50.25%。 前十大AH股溢价率排行 前十大AH股偏离值排行 | 股票名称 | H股(港元) | A股 | 溢价率 | 偏离值↓ | | --- | --- | --- | --- | --- | | 安德利果汁(02218) | 18.350 | 47.98 | 213.19% | 21.03% | | 金力永磁(06680) | 19.090 | 28.17 | 76.74% | 11.03% | ...

格隆汇8月11日丨钧达股份(02865.HK)公告，董事会会议将于2025年8月25日(星期一)举行，藉以(其中包 括)审议及批准公司及其附属公司截至2025年6月30日止6个月未经审计中期业绩及其刊发。 ...

海 南 鈞 達 新 能 源 科 技 股 份 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，董 事會會議將於2025年8月25日（星 期 一）舉 行，藉 以（其 中 包 括）審 議 及 批 准 本 公 司 及其附屬公司截至2025年6月30日 止 六 個 月 之 未 經 審 計 中 期 業 績 及 其 刊 發。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Hainan Drinda New Energy Technology Co., Ltd. 海南鈞達新能源科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：02865） 董事會會議通告 承董事會命 海南鈞達新能源科技股份有限公司 董事長兼執行董事 陸徐楊先生 香 港，2025年8月11日 截 至 本 公 告 日 期，董 事 會 成 員 包 括 執 行 董 事 陸 徐 楊 先 生、張 滿 良 先 生 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Hainan Drinda New Energy Technology Co., Ltd. 海南鈞達新能源科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：02865） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 作 出。 茲載列海南鈞達新能源科技股份有限公司在深圳證券交易所網站刊登了以下 公 告。茲 載 列 如 下，僅 供 參 閱。 特 此 公 告。 承董事會命 海南鈞達新能源科技股份有限公司 董事長兼執行董事 陸徐楊先生 中 國 • 海 口 2025年8月1日 截 至 本 公 告 日 期，董 事 會 成 員 為 執 行 董 事 陸 徐 楊 先 生、張 滿 良 先 生 及 鄭 洪 偉 先 生；非 執 行 董 事 徐 曉 平 先 生 及 徐 勇 先 生；職 工 代 表 董 事 鄭 虹 女 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 海南鈞達新能源科技股份有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02865 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 63,432,300 | RMB | | 1 RMB | | 63,432,300 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 63,432,300 | RMB | | 1 RMB | | 63,432,300 | | 2. 股份分類 | 普通股 | 股份類別 | A | | ...

智通财经APP获悉，根据2025年7月31日披露数据，锦欣生殖（01951）、长飞光纤光缆（06869）、美 中嘉和（02453）港股通持股占比增加值最大，分别增加2.58%、2.38%、2.29%；上海復旦（01385）、 山东新华製药股份（00719）、钧达股份（02865）港股通持股占比减少值最大，分别减 少-1.70%、-1.37%、-1.25%。 在最近有统计数据的5个交易日内，宜搜科技（02550）、长飞光纤光缆（06869）、恆生中国企业 （02828）港股通持股占比增加值最大，分别增加14.75%、11.72%、7.36%；山东新华製药股份 （00719）、亚盛医药-B（06855）、重庆钢铁股份（01053）港股通持股占比减少值最大，分别减 少-3.89%、-2.94%、-2.70%。 具体数据如下（交易所数据根据T+2日结算）： 1、港股通最新日占比增持榜（前20名） | 公司名称 | 占比值变动 | 最新持股比例 | | --- | --- | --- | | 锦欣生殖(01951) | +2.58% | 51.76% | | 长飞光纤光缆(06869) | +2.38% | 44.07 ...